Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis
Reads0
Chats0
TLDR
In this paper, the authors classified and summarized the anti-angiogenic natural agents (Polyphenols, Polysaccharides, Alkaloids, Terpenoids, Saponins) in targeting various tumor types according to their chemical structures, and discussed the mechanistic principles of these natural products on regulating angiogenesis-associated cytokines and apoptotic signaling pathways.Abstract:
Tumor-associated angiogenesis is a key target for anti-cancer therapy. The imbalance between pro-angiogenic and anti-angiogenic signals elicited by tumor cells or tumor microenvironment always results in activating "angiogenic switch". Tumor angiogenesis functions in multi-aspects of tumor biology, including endothelial cell apoptosis, tumor metastasis, and cancer stem cell proliferation. Numerous studies have indicated the important roles of inexpensive and less toxic natural products in targeting tumor angiogenesis-associated cytokines and apoptotic signaling pathways. Our current knowledge of tumor angiogenesis is based mainly on experiments performed on cells and animals, so we summarized the well-established models for angiogenesis both in vitro and in vivo. In this review, we classified and summarized the anti-angiogenic natural agents (Polyphenols, Polysaccharides, Alkaloids, Terpenoids, Saponins) in targeting various tumor types according to their chemical structures at present, and discussed the mechanistic principles of these natural products on regulating angiogenesis-associated cytokines and apoptotic signaling pathways. This review is to help understanding the recent progress of natural product research for drug development on anti-tumor angiogenesis.read more
Citations
More filters
Journal ArticleDOI
Platinum-Titania Schottky Junction as Nanosonosensitizer, Glucose Scavenger, and Tumor Microenvironment-Modulator for Promoted Cancer Treatment.
TL;DR: In this article , a smart therapeutic nanoplatform is constructed by surface immobilization of glucose oxidase (GOx) onto a TiO2@Pt Schottky junction.
Journal ArticleDOI
Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis
Monica Chung,Sang Jun Han +1 more
TL;DR: Current knowledge of the molecular etiology of endometriosis-associated angiogenesis is examined and anti-angiogenic therapy is discussed as potential non-hormonal therapy for the treatment of endometricriosis.
Journal ArticleDOI
Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression
TL;DR: This work classifies the receptors by their structures and functions, illustrates the natural compounds targeting these receptors and discusses the mechanisms of their anti-cancer activities.
Journal ArticleDOI
Saponins as cytotoxic agents: an update (2010–2021). Part II—Triterpene saponins
Irma Podolak,Karolina Grabowska,Danuta Sobolewska,Dagmara Wróbel-Biedrawa,Justyna Makowska-Was,Agnieszka Galanty +5 more
TL;DR: A review of Saponins as cytotoxic agents can be found in this article , where the main focus is on structure-activity relationships and molecular mechanisms of action with a main focus on triterpene saponins.
Journal ArticleDOI
Gastric Cancer-Derived Extracellular Vesicles (EVs) Promote Angiogenesis via Angiopoietin-2
Talya Kalfon,Shelly Loewenstein,Fabian Gerstenhaber,Stav Leibou,Hen Geller,Osnat Sher,Eran Nizri,Guy Lahat +7 more
TL;DR: The crosstalk between gastric cancer and endothelial cells mediated by vesicles is explored, with a specific focus on angiopoietin-2, and suggests a new mechanism via which GC cells induce angiogenesis.
References
More filters
Journal ArticleDOI
Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis.
Peter Carmeliet,Maria Grazia Lampugnani,Lieve Moons,F. Breviario,Veerle Compernolle,Françoise Bono,Giovanna Balconi,Raffaella Spagnuolo,Bert Oosthuyse,Mieke Dewerchin,Adriana Zanetti,Anne Angellilo,Virginie Mattot,Dieter Nuyens,Esther Lutgens,Frédéric Clotman,Marco C. De Ruiter,Adriana Gittenberger De Groot,Robert E. Poelmann,Florea Lupu,Jean Marc Herbert,Desire Collen,Elizabetta Dejana,Elizabetta Dejana +23 more
TL;DR: Targeted inactivation or truncation of the beta-catenin-binding cytosolic domain of the VE-cadherin gene was found to affect assembly of endothelial cells in vascular plexi, but to impair their subsequent remodeling and maturation, causing lethality at 9.5 days of gestation.
Journal ArticleDOI
Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells
TL;DR: Findings indicate that Bcl-2 plays an important role in mediating the survival activity of VEGF on endothelial cells, and overexpression of B cl-2 by means of transient biolistic transfection experiments of HUVE cells was sufficient to prevent endothelial Cells from apoptotic cell death in the absence of V EGF.
Journal ArticleDOI
Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor‐2
Raffaella Soldi,Stefania Mitola,Marina Strasly,Paola Defilippi,Guido Tarone,Federico Bussolino +5 more
TL;DR: A new role for αvβ3 integrin is indicated in the activation of an in vitro angiogenic program in endothelial cells by participating in the full activation of VEGFR‐2 triggered by VEGF‐A, which is an importantAngiogenic inducer in tumors, inflammation and tissue regeneration.
Journal ArticleDOI
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Laura Bonapace,Marie-May Coissieux,Jeffrey Wyckoff,Jeffrey Wyckoff,Kirsten D. Mertz,Zsuzsanna Varga,Tobias Junt,Mohamed Bentires-Alj +7 more
TL;DR: The results call for caution when considering anti-CCL2 agents as monotherapy in metastatic disease and highlight the tumour microenvironment as a critical determinant of successful anti-metastatic therapy.
Journal ArticleDOI
Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
Diego O. Croci,Juan P. Cerliani,Tomás Dalotto-Moreno,Santiago P. Méndez-Huergo,Ivan D. Mascanfroni,Sebastián Dergan-Dylon,Marta A. Toscano,Julio J. Caramelo,Juan J. Garcia-Vallejo,Jing Ouyang,Enrique A. Mesri,Melissa R. Junttila,Carlos Bais,Margaret A. Shipp,Mariana Salatino,Gabriel A. Rabinovich,Gabriel A. Rabinovich +16 more
TL;DR: A glycosylation-dependent pathway is identified that compensates for the absence of cognate ligand and preserves angiogenesis in response to VEGF blockade and may increase the efficacy of anti-VEGF treatment.